RILPL2: A Drug Target / Disease Biomarker (G196383)

Target Name: RILPL2

NCBI ID: G196383

RILPL2

RILPL2: A Drug Target / Disease Biomarker

RNA-Instrumented RNA-Instrumented Ligation Assay (RILPL2) is a technique that has been widely used in the study of RNA structure and function. This technique allows researchers to study the stability and stability interactions of RNA molecules, which is important for understanding various biological processes.

One of the key applications of RILPL2 is its ability to identify potential drug targets. By using this technique to study the behavior of RNA molecules, researchers can identify specific molecules that are likely to be involved in a variety of biological processes, including disease.

One of the key advantages of RILPL2 is its ability to study the stability and stability interactions of RNA molecules in a high-throughput manner. This means that researchers can quickly and efficiently identify potential drug targets by using this technique to study the behavior of large numbers of RNA molecules.

In addition to its use as a drug target, RILPL2 has also been widely used as a biomarker for various diseases. For example, this technique has been used to study the behavior of RNA molecules in the context of cancer, where it has been shown to be highly stable and interacting.

Overall, RILPL2 is a powerful tool for the study of RNA molecules and their behavior. Its ability to identify potential drug targets and serve as a biomarker makes it an important tool for researchers to study a wide range of biological processes.

Protein Name: Rab Interacting Lysosomal Protein Like 2

Functions: Involved in cell shape and neuronal morphogenesis, positively regulating the establishment and maintenance of dendritic spines (By similarity). Plays a role in cellular protein transport, including protein transport away from primary cilia (By similarity). May function via activation of RAC1 and PAK1 (By similarity)

The "RILPL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RILPL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets